Cat# : VAC-0006
|Product Name:||Recombinant Dendritic Cells Vaccine|
|Description:||The recombinant chimeric DC vaccine is a subunit-based vaccine candidate investigated for safety and effectiveness against SARS-CoV-2-induced pneumonia. With a better safety profile than inactivated and live-attenuated virus and virus-vector vaccines, the recombinant chimeric DC vaccine reduces the risk of virulence recovery, pre-existing anti-vector immunity, and incomplete viral inactivation. As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials.|
|Biologic Classification:||Vaccines Recombinant|
For more information on how our products could help advance your project, please contact us.
ENTER YOUR EMAIL HERE TO SUBSCRIBE.
Copyright © Creative BioMart. All Rights Reserved.